Literature DB >> 20688041

Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?

Domenico Martinelli1, Isabella Bitetto, Silvio Tafuri, Pietro L Lopalco, Rosa Maria Mininni, Rosa Prato.   

Abstract

Temporal trends of Hepatitis A cases and vaccination coverage data against Hepatitis A Virus have been investigated to analyse the impact of the universal routine vaccination strategy more than 10 years from its introduction in Puglia (region of Southern Italy). The basic reproductive number (R(0)) before vaccination introduction and the effective reproductive number (R(e)) after introduction have been calculated. A progressive decrease in incidence has been recorded in Puglia during last 10 years. Vaccination coverage is actually 64.8% (95% CI: 52.7-76.9%) for children aged 12-24 months and of 67.6% (95% CI: 58.4-76.8%) for 12-year-old adolescents. R(0) estimated in 1996 was 2.01; actually R(e) is 0.651. Theoretical age at infection is 31.82 years. Universal routine vaccination aimed at the control of direct transmission remains the milestone in the strategy for the containment of the disease in settings at an intermediate level of endemicity.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688041     DOI: 10.1016/j.vaccine.2010.07.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Time trends in pediatric hospitalizations for hepatitis A in Greece (1999-2013): Assessment of the impact of universal infant immunization in 2008.

Authors:  V Papaevangelou; Z Alexopoulou; C Hadjichristodoulou; G Kourlamba; A Katsioulis; K Theodoridou; V Spoulou; M Theodoridou
Journal:  Hum Vaccin Immunother       Date:  2016-05-04       Impact factor: 3.452

2.  Modelling the force of infection for hepatitis A in an urban population-based survey: a comparison of transmission patterns in Brazilian macro-regions.

Authors:  Ricardo Arraes de Alencar Ximenes; Celina Maria Turchi Martelli; Marcos Amaku; Ana Marli C Sartori; Patricia Coelho de Soárez; Hillegonda Maria Dutilh Novaes; Leila Maria Moreira Beltrão Pereira; Regina Célia Moreira; Gerusa Maria Figueiredo; Raymundo Soares de Azevedo
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

3.  Considerations on the current universal vaccination policy against hepatitis A in Greece after recent outbreaks.

Authors:  Kassiani Mellou; Theologia Sideroglou; Vassiliki Papaevangelou; Anna Katsiaflaka; Nikolaos Bitsolas; Eleni Verykouki; Eleni Triantafillou; Agoritsa Baka; Theano Georgakopoulou; Christos Hadjichristodoulou
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

4.  Serosurveillance of hepatitis A in a region which adopted the universal mass vaccination.

Authors:  Maria Filomena Gallone; Francesco Desiante; Maria Serena Gallone; Giovanna Barbuti; Silvio Tafuri; Cinzia Germinario
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 5.  Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.

Authors:  Anke L Stuurman; Cinzia Marano; Eveline M Bunge; Laurence De Moerlooze; Daniel Shouval
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

6.  Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination.

Authors:  Maria Chironna; Rosa Prato; Anna Sallustio; Domenico Martinelli; Silvio Tafuri; Michele Quarto; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2012-10-25       Impact factor: 3.090

7.  Estimating the critical immunity threshold for preventing hepatitis A outbreaks in men who have sex with men.

Authors:  D G Regan; J G Wood; C Benevent; H Ali; L Watchirs Smith; P W Robertson; M J Ferson; C K Fairley; B Donovan; M G Law
Journal:  Epidemiol Infect       Date:  2015-11-13       Impact factor: 4.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.